Zobrazeno 1 - 10
of 57
pro vyhledávání: '"B, Puchner"'
Autor:
Julia Karady, Robert W McGarrah, Maggie Nguyen, Stephanie N Giamberardino, Nandini Meyersohn, Michael T Lu, Pedro V Staziaki, Stefan B Puchner, Daniel O Bittner, Borek Foldyna, Thomas Mayrhofer, Margery A Connelly, Andre Tchernof, Phillip J White, Khurram Nasir, Kathleen Corey, Deepak Voora, Neha Pagidipati, Geoffrey S Ginsburg, William E Kraus, Udo Hoffmann, Pamela S Douglas, Svati H Shah, Maros Ferencik
Publikováno v:
American Journal of Preventive Cardiology, Vol 18, Iss , Pp 100680- (2024)
Objectives: To determine the relationship between lipoprotein particle size/number with hepatic steatosis (HS), given its association with traditional lipoproteins and coronary atherosclerosis. Methods: Individuals with available CT data and blood sa
Externí odkaz:
https://doaj.org/article/44e227185ee8468e8195c9e37a5c8c32
Autor:
Julia Karády, Maros Ferencik, Thomas Mayrhofer, Nandini M. Meyersohn, Daniel O. Bittner, Pedro V. Staziaki, Balint Szilveszter, Travis R. Hallett, Michael T. Lu, Stefan B. Puchner, Tracey G. Simon, Borek Foldyna, Geoffrey S. Ginsburg, Robert W. McGarrah, Deepak Voora, Svati H. Shah, Pamela S. Douglas, Udo Hoffmann, Kathleen E. Corey
Publikováno v:
Hepatology Communications, Vol 6, Iss 12, Pp 3406-3420 (2022)
Abstract Cardiovascular disease (CVD) is the leading cause of mortality in adults with hepatic steatosis (HS). However, risk factors for CVD in HS are unknown. We aimed to identify factors associated with coronary artery disease (CAD) and incident ma
Externí odkaz:
https://doaj.org/article/a24857b7a81141318f46482d688d76b6
Autor:
Maros Ferencik, Thomas Mayrhofer, Michael T. Lu, Daniel O. Bittner, Hamed Emami, Stefan B. Puchner, Nandini M. Meyersohn, Alexander V. Ivanov, Elizabeth C. Adami, Deepak Voora, Geoffrey S. Ginsburg, James L. Januzzi, Pamela S. Douglas, Udo Hoffmann
Publikováno v:
JACC: Cardiovascular Imaging. 15:1427-1438
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7010346bc2309b9dff391b16527f2abc
https://doi.org/10.1016/j.jcmg.2022.03.016
https://doi.org/10.1016/j.jcmg.2022.03.016
Autor:
Dai Fukumura, Rakesh K. Jain, Dan G. Duda, Raquel Soares, Peter Carmeliet, Masabumi Shibuya, Marek Ancukiewicz, Udo Hoffmman, Christopher L. Schlett, Stefan B. Puchner, Ian E. Krop, Jennifer A. Ligibel, Tai Hato, Anna Khachatryan, Keehoon Jung, Suboj Babykutty, Ana Batista, Trupti D. Vardam, Shan M. Chin, Dan T. McManus, Priya Suboj, Nuh N. Rahbari, Josh Tam, Joao Incio
Supplementary Figure 3 - Expression of VEGFR-1 and IL-1ß in TAMs in PAN02 tumors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6749edf95c19e2470f7e6961e97228d8
https://doi.org/10.1158/1078-0432.22459802
https://doi.org/10.1158/1078-0432.22459802
Autor:
Dai Fukumura, Rakesh K. Jain, Dan G. Duda, Raquel Soares, Peter Carmeliet, Masabumi Shibuya, Marek Ancukiewicz, Udo Hoffmman, Christopher L. Schlett, Stefan B. Puchner, Ian E. Krop, Jennifer A. Ligibel, Tai Hato, Anna Khachatryan, Keehoon Jung, Suboj Babykutty, Ana Batista, Trupti D. Vardam, Shan M. Chin, Dan T. McManus, Priya Suboj, Nuh N. Rahbari, Josh Tam, Joao Incio
Effects of VEGFR-1 signaling ablation on E0771 tumor growth, vascular and immune environment in lean and obese mice.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b6bea20411e58e3f009f2c5fb491923
https://doi.org/10.1158/1078-0432.22459790.v1
https://doi.org/10.1158/1078-0432.22459790.v1
Autor:
Dai Fukumura, Rakesh K. Jain, Dan G. Duda, Raquel Soares, Peter Carmeliet, Masabumi Shibuya, Marek Ancukiewicz, Udo Hoffmman, Christopher L. Schlett, Stefan B. Puchner, Ian E. Krop, Jennifer A. Ligibel, Tai Hato, Anna Khachatryan, Keehoon Jung, Suboj Babykutty, Ana Batista, Trupti D. Vardam, Shan M. Chin, Dan T. McManus, Priya Suboj, Nuh N. Rahbari, Josh Tam, Joao Incio
Supplementary Figure 5 - Effects of VEGFR-1 signaling ablation on PAN02 tumor progression in body-weight matched mice.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ad91bf51dc944b96a2629d38143694a
https://doi.org/10.1158/1078-0432.22459796.v1
https://doi.org/10.1158/1078-0432.22459796.v1
Autor:
Dai Fukumura, Rakesh K. Jain, Dan G. Duda, Raquel Soares, Peter Carmeliet, Masabumi Shibuya, Marek Ancukiewicz, Udo Hoffmman, Christopher L. Schlett, Stefan B. Puchner, Ian E. Krop, Jennifer A. Ligibel, Tai Hato, Anna Khachatryan, Keehoon Jung, Suboj Babykutty, Ana Batista, Trupti D. Vardam, Shan M. Chin, Dan T. McManus, Priya Suboj, Nuh N. Rahbari, Josh Tam, Joao Incio
Supplementary Figure 10 - Additional measurements of PlGF and VEGF-B; Supplementary Figure 11 - Additional effects of PlGF deletion on obesity-induced tumor progression and systemic metabolism.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b3b0714fcdca44bec71c86b29b820cd
https://doi.org/10.1158/1078-0432.22459784
https://doi.org/10.1158/1078-0432.22459784
Autor:
Dai Fukumura, Rakesh K. Jain, Dan G. Duda, Raquel Soares, Peter Carmeliet, Masabumi Shibuya, Marek Ancukiewicz, Udo Hoffmman, Christopher L. Schlett, Stefan B. Puchner, Ian E. Krop, Jennifer A. Ligibel, Tai Hato, Anna Khachatryan, Keehoon Jung, Suboj Babykutty, Ana Batista, Trupti D. Vardam, Shan M. Chin, Dan T. McManus, Priya Suboj, Nuh N. Rahbari, Josh Tam, Joao Incio
Effects of VEGFR-1 signaling ablation on glucose/insulin tolerance and insulin production by the pancreas during obesity.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3458581491499855437beed8ac0b579c
https://doi.org/10.1158/1078-0432.22459793
https://doi.org/10.1158/1078-0432.22459793
Autor:
Dai Fukumura, Rakesh K. Jain, Dan G. Duda, Raquel Soares, Peter Carmeliet, Masabumi Shibuya, Marek Ancukiewicz, Udo Hoffmman, Christopher L. Schlett, Stefan B. Puchner, Ian E. Krop, Jennifer A. Ligibel, Tai Hato, Anna Khachatryan, Keehoon Jung, Suboj Babykutty, Ana Batista, Trupti D. Vardam, Shan M. Chin, Dan T. McManus, Priya Suboj, Nuh N. Rahbari, Josh Tam, Joao Incio
Purpose: Obesity promotes pancreatic and breast cancer progression via mechanisms that are poorly understood. Although obesity is associated with increased systemic levels of placental growth factor (PlGF), the role of PlGF in obesity-induced tumor p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::641566e68fb66ddcdbfc128867ee2814
https://doi.org/10.1158/1078-0432.c.6524309
https://doi.org/10.1158/1078-0432.c.6524309
Autor:
Dai Fukumura, Rakesh K. Jain, Dan G. Duda, Raquel Soares, Peter Carmeliet, Masabumi Shibuya, Marek Ancukiewicz, Udo Hoffmman, Christopher L. Schlett, Stefan B. Puchner, Ian E. Krop, Jennifer A. Ligibel, Tai Hato, Anna Khachatryan, Keehoon Jung, Suboj Babykutty, Ana Batista, Trupti D. Vardam, Shan M. Chin, Dan T. McManus, Priya Suboj, Nuh N. Rahbari, Josh Tam, Joao Incio
Supplementary Figure 1 - A) Vessel density in PAN02 tumors from lean and obese mice, and effect of VEGFR-1-TK-deletion on tumor vessel density and hypoxia markers in obese mice. Supplementary Figure 2 - Gene expression of M1 / M2 markers in TAMs isol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70e03d881ee4aad5e3ce070a22a23a25
https://doi.org/10.1158/1078-0432.22459787
https://doi.org/10.1158/1078-0432.22459787